A new approach to cardiac CT scanning can now uncover both obvious and “invisible” heart damage, potentially predicting future heart failure, hospitalisation, and death from a single non‑invasive test.
How the Technique Works
Researchers at Kumamoto University enhanced a standard cardiac Computed Tomography (CT) scan by adding a delayed imaging phase and analysing two key markers:
- Late Iodine Enhancement (LIE): highlights localised scarring in the heart muscle, often from prior heart attacks or chronic injury.
- Extracellular Volume (ECV) fraction: quantifies subtle, diffuse damage spread through the muscle, such as fibrosis or inflammation that is not visible on a routine scan.
By combining these two markers, the CT captures a “synergistic” picture of both structural and micro‑scale injury, going beyond traditional coronary‑blockage checks.
Accuracy and Clinical Impact
In a study of 1,207 patients followed over an average of 26 months, abnormalities in both LIE and ECV strongly predicted unplanned hospitalisations or death from cardiovascular causes. The technique provides a faster, more accessible alternative to lengthy or expensive tests like MRI, allowing doctors to spot high‑risk patients earlier and start targeted treatments, from intensive medical therapy to lifestyle intervention, before crises occur.
Broader Shift in Cardiac Care
This development fits into a broader move toward using advanced imaging and AI to turn routine scans into preventive tools, picking up “hidden” damage or risk years before obvious symptoms appear. For patients, it means a standard‑looking CT might soon double as an early‑warning system for long‑term heart health, helping to shift cardiology from reactive crisis management to proactive, personalised risk management.
